z-logo
Premium
Minoxidil in the treatment of androgenetic alopecia
Author(s) -
Goren Andy,
Naccarato Ty
Publication year - 2018
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12686
Subject(s) - minoxidil , medicine , hair loss , dermatology , male pattern baldness , drug , pharmacology , scalp
The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over‐the‐counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil for the treatment of AGA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here